| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/09/2008 | EP1908472A1 Silicon derivatives for PET imaging |
| 04/09/2008 | EP1908471A1 Tetrahydropyridines as renin inhibitors |
| 04/09/2008 | EP1908470A1 Peritoneum protecting agent |
| 04/09/2008 | EP1908469A1 Angiotensin II receptor antagonist for the treatment of systemic diseases in cats |
| 04/09/2008 | EP1908468A1 Aerosol formula for inhalation containing an anticholinergic agent |
| 04/09/2008 | EP1908467A1 Herpesvirus-derived therapeutic agent for pain |
| 04/09/2008 | EP1908466A1 Substituted propanamide derivative and pharmaceutical composition containing the same |
| 04/09/2008 | EP1908465A1 Use of chlorine guanabenz derivatives for treating prion-based diseases |
| 04/09/2008 | EP1908463A2 Methods of inducing ovulation using a non-polypeptide camp level modulator |
| 04/09/2008 | EP1908462A2 Dichloroacetate in combination with cardioprotective or hemodynamic drugs |
| 04/09/2008 | EP1908461A1 Use of (1S, 2R) enantiomer of milnacipran for the preparation of a medicine |
| 04/09/2008 | EP1908460A1 Use of (1R, 2R)-3-(2-dimethyl amino methyl-cyclohexyl) phenol for treating painful inflammations |
| 04/09/2008 | EP1908459A1 Composition for prevention of cancer |
| 04/09/2008 | EP1908458A1 Volatile anaesthetic with xenon |
| 04/09/2008 | EP1908457A1 Composition based on salts of hyaluronic acid for treating epithelial lesions |
| 04/09/2008 | EP1908453A1 Alkyl ether citrates for selective cleansing of skin |
| 04/09/2008 | EP1907546A2 Rnai for control of insects and arachnids |
| 04/09/2008 | EP1907530A2 Compositions and methods for treating tissue |
| 04/09/2008 | EP1907407A1 Improvements to analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation |
| 04/09/2008 | EP1907406A1 Crystalline forms of macrolide compounds endowed with antiinflammatory activity |
| 04/09/2008 | EP1907405A1 Thiocolchicoside analogues with myorelaxant and anti-inflammatory activity |
| 04/09/2008 | EP1907403A2 Antiviral compounds |
| 04/09/2008 | EP1907399A1 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as cxc-chemokine receptor ligands |
| 04/09/2008 | EP1907398A1 Therapeutic agents |
| 04/09/2008 | EP1907395A1 Abca1 elevating compounds |
| 04/09/2008 | EP1907394A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| 04/09/2008 | EP1907392A1 Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase |
| 04/09/2008 | EP1907389A2 Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein |
| 04/09/2008 | EP1907388A1 Novel heteroaryl fused cyclic amines |
| 04/09/2008 | EP1907387A1 An oxime derivative and preparations thereof |
| 04/09/2008 | EP1907386A1 Amino acid salts of rosiglitazone |
| 04/09/2008 | EP1907385A2 Compounds |
| 04/09/2008 | EP1907383A1 Gpcr agonists |
| 04/09/2008 | EP1907382A1 Nitrocatechol derivatives as comt inhibitors |
| 04/09/2008 | EP1907381A1 Antidiabetic oxazolidinediones and thiazolidinediones |
| 04/09/2008 | EP1907380A2 Process to obtain synthetic and semi-synthetic lignan derivatives, their antiparasitic activities and corresponding pharmaceutical formulations, including the therapeutic method using said lignan for the treatment of parasitosis |
| 04/09/2008 | EP1907379A1 Crystalline forms of (2r-trans)-6-chloro-5ýý4-ý(4-fluorophenyl)methyl¨-2,5-dimethyl-1-piperazinyl¨carbonyl¨-n,n, 1-trimethyl-alpha-oxo-1h-indole-3-acetamide monohydrochloride |
| 04/09/2008 | EP1907376A2 Stereoisomeric pyridyl and pyridonyl compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
| 04/09/2008 | EP1907372A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists |
| 04/09/2008 | EP1907370A2 Novel 1,4-benzothiazepine-1,1-dioxide derivative having improved properties, method for the production thereof, medicaments containing said compound, and use thereof |
| 04/09/2008 | EP1907369A1 Thiazoles derivatives as ampk activator |
| 04/09/2008 | EP1907368A1 2-cyano-pyrimidines and -triazines as cysteine protease inhibitors |
| 04/09/2008 | EP1907367A1 Design and synthesis of novel tubulin polymerization inhibitors: bonzoylphenyluria (bpu) sulfur analogs |
| 04/09/2008 | EP1907365A1 Salts of substituted pyrazoline compounds, their preparation and use as medicaments |
| 04/09/2008 | EP1907364A1 Aripiprazole salts |
| 04/09/2008 | EP1907363A1 Phenyl substituted piperazine-derivatives as inhibitors of plaminogenic activator inhibitors-i (pai-i) |
| 04/09/2008 | EP1907362A1 Amide derivatives as kinase inhibitors |
| 04/09/2008 | EP1907361A1 Amide derivatives as kinase inhibitors |
| 04/09/2008 | EP1907359A2 3,5-substituted piperidine derivatives effective on renin-related disorders |
| 04/09/2008 | EP1907358A2 Bicyclic derivatives as p38 kinase inhibitors |
| 04/09/2008 | EP1907357A1 Aniline sulfonamide derivatives and their uses |
| 04/09/2008 | EP1907351A1 HCl POLYMORPHS OF 3 -(2-(DIMETHYLAMINO)METHYL(CYCLOHEX-1-YL))PHENOL |
| 04/09/2008 | EP1907350A1 Salt of fumaric acid and 3-(2-dimethylamino)methyl(cyclohex-1-yl))phenol and its crystalline forms |
| 04/09/2008 | EP1907027A2 Medical devices and coatings therefor |
| 04/09/2008 | EP1907013A2 Compositions and methods for the treatment or prevention of chemoresistant neoplasia |
| 04/09/2008 | EP1907009A1 Use of aprotinin polypeptides as carriers in pharmaceutical conjugates |
| 04/09/2008 | EP1907006A2 Prevention and treatment of ophthalmic complications of diabetes |
| 04/09/2008 | EP1907005A1 Compositions for affecting weight loss |
| 04/09/2008 | EP1907004A2 Combination of a renin inhibitor and an insulin secretion enhancer or an insulin sensitizer |
| 04/09/2008 | EP1906996A2 Method for genetic immunization by electrotransfer against a toxin and antiserum obtainable by said method |
| 04/09/2008 | EP1906991A2 Use of glp-1 receptor agonists and/or dpp-iv inhibitors in combination with proton pump inhibitors and ppar agonists for the preparation of a medicament for the treatment of diabetes type i, diabetes type ii and impaired pancreatic beta-cell function |
| 04/09/2008 | EP1906987A1 Methods and compositions for emergency contraception using endothelin receptor antagonists |
| 04/09/2008 | EP1906977A1 Stabilized chlorite solutions in combination with fluoropyrimidines for cancer treatment. |
| 04/09/2008 | EP1906976A2 Therapeutic polymers and methods of use |
| 04/09/2008 | EP1906975A2 Method for treating sickle cell disease and sickle cell disease sequelae |
| 04/09/2008 | EP1906974A2 Heparin compostions and selectin inhibition |
| 04/09/2008 | EP1906973A2 Pharmaceutical formulations for minimizing drug-drug interactions |
| 04/09/2008 | EP1906971A2 Antiviral compounds |
| 04/09/2008 | EP1906970A2 Use of non-antibacterial tetracycline formulations for inhibiting bacterial spores |
| 04/09/2008 | EP1906969A2 Methods for treating and diagnosing complications of premature birth |
| 04/09/2008 | EP1906968A2 New regimens for oral monophasic contraceptives |
| 04/09/2008 | EP1906967A2 Abl kinase inhibition |
| 04/09/2008 | EP1906966A2 Compositions for reducing the incidence of drug induced arrhythmia |
| 04/09/2008 | EP1906965A2 Azaindazole compounds and methods of use |
| 04/09/2008 | EP1906964A1 Piperazinone derivatives useful as histamine h3 receptor antagonists and/or inverse agonists |
| 04/09/2008 | EP1906963A2 Method of treating ischemia-reperfusion injury |
| 04/09/2008 | EP1906962A2 Octahydroisoquinoline compounds as opioid receptor modulators |
| 04/09/2008 | EP1906961A2 Solid dosage formulations of narcotic drugs having improved buccal adsorption |
| 04/09/2008 | EP1906960A1 New combination 1 |
| 04/09/2008 | EP1906959A1 Novel epilepsy treatment |
| 04/09/2008 | EP1906958A2 Pyrazolo[3,4-b]pyridin-2-yl]-benzoic acid derivatives as hiv integrase inhibitors |
| 04/09/2008 | EP1906957A1 Novel use of activators and stimulators of soluble guanylate cyclase for the prevention or treatment of renal disorders |
| 04/09/2008 | EP1906956A2 Use of thiazole derivatives and analogues in disorders caused by free fatty acids |
| 04/09/2008 | EP1906955A2 Use of thiazole derivatives and analogues in the treatment of cancer |
| 04/09/2008 | EP1906954A1 Bicyclic 6-alkylidene-penem b-lactamase inhibitors and -lactam antibiotic combination: a broad spectrum antibiotic |
| 04/09/2008 | EP1906953A1 Acid and base salt forms of gaboxadol |
| 04/09/2008 | EP1906952A1 Mao-b inhibitors useful for treating obesity |
| 04/09/2008 | EP1906951A2 Compositions and methods for treating gastrointestinal hypomotility and associated disorders |
| 04/09/2008 | EP1906950A2 Ansamycin formulations and methods of use thereof |
| 04/09/2008 | EP1906949A1 Use of l-carnitine or of alkanoyl l-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye-drops |
| 04/09/2008 | EP1906948A2 Treatment of cancer |
| 04/09/2008 | EP1906947A1 A photosensitising composition and uses thereof |
| 04/09/2008 | EP1906946A2 Methods of treating epileptogenesis |
| 04/09/2008 | EP1906945A2 Hcv inhibitors |
| 04/09/2008 | EP1906944A1 Schisandrin b preparation |
| 04/09/2008 | EP1906943A1 Transdermal patch comprising paroxetine |
| 04/09/2008 | EP1906938A2 Pharmaceutical formulation of nitrooxyderivatives of nsaids |
| 04/09/2008 | EP1906937A2 Novel dispersible tablet composition |
| 04/09/2008 | EP1906936A2 Formulations containing losartan and/or its salts |
| 04/09/2008 | EP1906933A2 Novel pharmaceutical modified release dosage form cyclooxygenase enzyme inhibitor |